e-learning
resources
Paris 2018
Monday, 17.09.2018
Diagnostics including questionnaires
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sleep apnea screening questionnaires in patients with type 2 diabetes.
A. Pataka (Thessaloniki, Greece), S. Kotoulas (Thessaloniki, Greece), G. Kalamaras (Thessaloniki, Greece), E. Panagiotidou (Thessaloniki, Greece), V. Chatzopoulos (Thessaloniki, Greece), K. Fekete (Thessaloniki, Greece), P. Argyropoulou (Thessaloniki, Greece)
Source:
International Congress 2018 – Diagnostics including questionnaires
Session:
Diagnostics including questionnaires
Session type:
Thematic Poster
Number:
2515
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Pataka (Thessaloniki, Greece), S. Kotoulas (Thessaloniki, Greece), G. Kalamaras (Thessaloniki, Greece), E. Panagiotidou (Thessaloniki, Greece), V. Chatzopoulos (Thessaloniki, Greece), K. Fekete (Thessaloniki, Greece), P. Argyropoulou (Thessaloniki, Greece). Sleep apnea screening questionnaires in patients with type 2 diabetes.. 2515
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012
Prevalence of obstructive sleep apnoea in men with type 2 diabetes
Source: Eur Respir J 2005; 26: Suppl. 49, 567s
Year: 2005
Late Breaking Abstract - An assessment of medical utilization across procedure codes in patients with sleep apnea and type 2 diabetes
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Hypertension among obstructive sleep apnea patients compared to controls. Two year change after starting treatment with CPAP
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013
The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence
Source: Sleep and Breathing Conference 2021
Year: 2021
Type 2 diabetes and the risk for obstructive sleep apnoea in Nigeria
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Sleep apnoea and diabetes: a complex relationship
Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities
Year: 2016
BOAH – A shorter version of STOP-BANG questionnaire for prioritizing patients for polysomnography in sleep clinic
Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea
Year: 2016
Obstructive sleep apnoea in patients with type 1 diabetes
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Sleep architecture and type 2 diabetes mellitus: Where’s the link?
Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults
Year: 2015
Sleep-disordered breathing is correlated to renal impairment in patients with diabetes mellitus type 2
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
Snoring and daytime sleepiness in women. Associations with hypertension and diabetes in a population-based sample
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004
Sleep apnea symptoms in diabetics and their first degree relatives
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Prevalence of restless legs syndrome among patients with obstructive sleep apnea before and after CPAP treatment, compared to the general population. The Icelandic Sleep Apnea Cohort (ISAC)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
NoSAS: a possible screening questionnaire in patients with OSA and comorbidities
Source: Virtual Congress 2020 – New insights into sleep apnoea: from diagnosis to treatment
Year: 2020
LATE-BREAKING ABSTRACT: Clinical outcomes and cost-effectiveness of using positive airways pressure to manage sleep apnoea in patients with type 2 diabetes in the UK.
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013
STOP-BANG questionnaire overestimates sleep apnea in asthmatic patients with nocturnal symptoms
Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea
Year: 2016
Prevalence of high risk population for obstructive sleep apnea using STOP-BANG questionnaire in a large urban population
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Cystatin C as a marker of cardiovascular diseases in patients with obstructive sleep apnea (OSA) with concomitant diabetes mellitus type 2 (DM2)
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept